Cart
sales@molnova.com
CU-CPT17e
CAS No. 2109805-75-4
CU-CPT17e( —— )
Catalog No. M23960 CAS No. 2109805-75-4
CU-CPT17e is a potent agonist of TLR(TLR3, TLR8, and TLR9).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 419 | In Stock |
|
| 10MG | 617 | In Stock |
|
| 25MG | 938 | In Stock |
|
| 50MG | 1293 | In Stock |
|
| 100MG | 1739 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCU-CPT17e
-
NoteResearch use only, not for human use.
-
Brief DescriptionCU-CPT17e is a potent agonist of TLR(TLR3, TLR8, and TLR9).
-
DescriptionCU-CPT17e is a potent agonist of TLR(TLR3, TLR8, and TLR9).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorTLR3|TLR8|TLR9
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2109805-75-4
-
Formula Weight504.49
-
Molecular FormulaC27H24N2O8
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM (Need ultrasonic and warming)
-
SMILESO=[N+]([O-])C(C=C1)=CC=C1COC2=CC(C=CC3(CCOCC3)O4)=C4C=C2OCC5=CC=C([N+]([O-])=O)C=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang L, et al. Discovery of Small Molecules as Multi-Toll-like Receptor Agonists with Proinflammatory and Anticancer Activities. J Med Chem. 2017 Jun 22;60(12):5029-5044.
molnova catalog
related products
-
Pam3CSK4
Pam3CSK4 is a synthetic triacylated lipopeptide (LP) that mimics the acylated amino terminus of bacterial LPs.
-
Procyanidin B1
Procyanidin B1, isolated from commonly eaten fruits, binds to the TLR4/MD-2 complex and has anti-inflammatory activity.Procyanidin B1 (100 μg/mL) inhibits LPS-induced TNF-α production, and expression of MD-2, TRAF6, NF-κB mRNA, phosphorylated p38 MAPK and NF-κB protein in THP1 cells.
-
MMG-11
MMG-11 is a potent and selective human TLR2 antagonist with low cytotoxicity. MMG-11 inhibits both TLR2/1 and TLR2/6 signaling with IC50s of 1.7?μM for Pam3CSK4-induced hTLR2/1 and 5.7?μM for Pam2CSK4-induced hTLR2/6 responses.
